1-2 of 2
John W. Ostrominski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of Heart Failure and Chronic Kidney Disease

John W. Ostrominski, Brian L. Claggett, Zi Michael Miao, Gerasimos Filippatos, Akshay S. Desai, Pardeep S. Jhund, Alasdair Henderson, Meike Brinker, Patrick Schloemer, Prabhakar Viswanathan, Andrea Lage, Katja Rohwedder, Carolyn S.P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faiez Zannad, Peter Rossing, Luis M. Ruilope, Stefan D. Anker, Bertram Pitt, Rajiv Agarwal, John J.V. McMurray, Scott D. Solomon, Muthiah Vaduganathan
Journal: Diabetes Care
Diabetes Care 2025;48(5):745–755
https://doi.org/10.2337/dc24-1873
Published: 28 February 2025
View articletitled, Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of Heart Failure and Chronic Kidney Disease
Open the PDF for Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of Heart Failure and Chronic Kidney Disease in another window
Journal Articles

Polypharmacy in Type 2 Diabetes: Appropriate or Cause for Concern?

Zeb I. Saeed, John W. Ostrominski, Vanita R. Aroda
Journal: Diabetes Care
Diabetes Care 2024;47(12):2104–2106
https://doi.org/10.2337/dci24-0035
Published: 27 November 2024
View articletitled, Polypharmacy in Type 2 Diabetes: Appropriate or Cause for Concern?
Open the PDF for Polypharmacy in Type 2 Diabetes: Appropriate or Cause for Concern? in another window